Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Momenta Pharmaceuticals Inc (NASDAQ:MNTA)

11.87
Delayed Data
As of Sep 23
 -0.22 / -1.82%
Today’s Change
7.86
Today|||52-Week Range
18.85
-20.01%
Year-to-Date
Two Things You Must Understand About Biotech Investing
Sep 11 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close12.09
Today’s open12.03
Day’s range11.84 - 12.14
Volume379,319
Average volume (3 months)541,507
Market cap$842.6M
Dividend yield--
Data as of 3:59pm ET, 09/23/2016

Growth & Valuation

Earnings growth (last year)+30.89%
Earnings growth (this year)+7.42%
Earnings growth (next 5 years)--
Revenue growth (last year)+71.58%
P/E ratioNM
Price/Sales10.45
Price/Book2.21

Competitors

 Today’s
change
Today’s
% change
RTRXRetrophin Inc-0.70-3.01%
AMAGAMAG Pharmaceuticals...+0.08+0.33%
BPMCBlueprint Medicines ...-0.51-1.75%
ANIPANI Pharmaceuticals ...-0.17-0.25%
Data as of 3:59pm ET, 09/23/2016

Financials

Next reporting dateNovember 2, 2016
EPS forecast (this quarter)-$0.29
Annual revenue (last year)$89.7M
Annual profit (last year)-$83.3M
Net profit margin-92.93%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO &
Class II Director
Craig A. Wheeler
Chief Operating Officer
Matthew P. Ottmer
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Search for Jobs